ARX vs HLS

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

ARX

AROA BIO FPO [ARX]

57MEDIUM

HLS

HEALIUS FPO [HLS]

54MEDIUM

Score Breakdown

ARX HLS
Technical
38
68
Catalyst
50
87
Sentiment
50
50
Fundamental
95
90
Momentum
55
34
Risk Gate
50
32

Key Metrics

ARX Metric HLS
$202.9MMarket Cap$275.9M
314KAvg Volume (20d)4.3M
N/AShort Interest+10.1%
$0.80052-Week High$1.070
$0.49552-Week Low$0.300
-0.8%Daily Change+3.2%
$0.580Reference Price$0.392
+4.9%ROE-69.3%
+4.5%Profit Margin-12.3%

Active Signals

ARX Signals

RSI drifting toward oversold territory — worth watching
Trading below both moving averages — the trend is working against this one
Above-average volume (1.6x) on a red day — sellers in control
Sitting near support — this level has held before and could attract buyers again
Drifting lower — down 3.3% over the last 5 days
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (2.0x)

HLS Signals

MACD momentum is picking up steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Trading above both moving averages — the trend is your friend here
Below the 200-day average — the long-term trend is still working against it
Cash positive / operating cashflow positive
Low P/S ratio (0.2x)
EPS estimates revised upward (+10pts)
Near 52-week low (10% of range)

Ask Scout AI to compare ARX and HLS in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

ARX vs IMC →ARX vs IMM →ARX vs LDX →ARX vs MAP →ARX vs MYX →
ARX Full Analysis → HLS Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).